Appvance.ai

About Appvance.ai

Appvance.ai provides a software quality assurance platform that leverages generative artificial intelligence to automate testing, aiming to disrupt the software quality assurance market. The company was established in 2012 by a team of AI and test automation experts, with Frank Cohen listed as a founder and Kevin Surace as a co-founder. Surace, a technology innovator with 94 worldwide patents, serves as the Chairman and CTO, while Andre Liao, an executive with nearly three decades of experience in the high-tech sector, holds the position of CEO. Liao's background includes leadership roles and expertise in enterprise technology sales and product development, complemented by a Master's degree from the USC Marshall School of Business and a Bachelor's from the University of California, Santa Cruz. Surace's entrepreneurial journey includes pioneering work on an early smartphone, a human-like AI virtual assistant that influenced GM's OnStar, and receiving accolades such as Inc. Magazine's 2009 Entrepreneur of the Year.

The company's core offering is Appvance IQ (AIQ), a unified test automation platform launched in late 2017. AIQ is designed for large enterprises to enhance the efficiency of their testing teams and the overall quality of their applications. The platform operates on a subscription-based model, with pricing tailored to organizational needs. It utilizes an AI/ML engine to design, generate, and execute tests for complex web and mobile applications, often without human intervention. The system supports a wide range of applications, including web, mobile, SOA services, and Oracle forms. Key features include AI-driven test generation, codeless script creation, unified testing capabilities (functional, performance, security), and integrations with CI/CD tools like Jenkins and Jira. AIQ can automatically generate thousands of test scripts, identify bugs, and provides detailed reporting and analytics. Recently, Appvance launched GENI, a generative AI feature that converts English test cases into test scripts, aiming to make manual testing obsolete.

Financially, Appvance.ai has secured a total of $24.2 million over five funding rounds. A significant milestone was the $13 million Series C funding round in January 2022, led by Arrowroot Capital. This funding was aimed at accelerating global expansion and product development following a period of substantial business growth. The company is headquartered in Santa Clara, California, with additional offices in Costa Rica and India to support its global customer base.